Related Experiment Video
Updated: Dec 11, 2025

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
Extracellular vesicles in cardiovascular diseases
Shihui Fu1,2, Yujie Zhang3, Yulong Li1
1Department of Geriatric Cardiology, Chinese People's Liberation Army General Hospital, Beijing, 100853 China.
Insights
Extracellular vesicles (EVs) are key to cell communication in cardiovascular health and disease. These vesicles, carrying micro-ribonucleic acids (miRs) and proteins, offer potential for new cardiovascular disease (CVD) prevention, diagnosis, and treatment strategies.
Area of Science:
- Cardiovascular Biology
- Cellular Communication
- Biomedical Research
Background:
- Cardiovascular diseases (CVDs) remain a leading global cause of mortality, necessitating novel therapeutic and diagnostic approaches.
- Cardiovascular function relies on intricate communication between various cardiac cell types.
- Extracellular vesicles (EVs) are crucial mediators of intercellular communication, transporting bioactive molecules like micro-ribonucleic acids (miRs) and proteins.
Purpose of the Study:
- To review the multifaceted roles of extracellular vesicles (EVs) in the context of cardiovascular diseases (CVDs).
- To explore the potential of EVs as diagnostic biomarkers and therapeutic agents for CVDs.
- To highlight how EV cargo composition changes in pathological conditions, influencing disease progression.
Main Methods:
- Literature review of studies investigating extracellular vesicles (EVs) in cardiovascular research.
- Analysis of the molecular cargo (miRs, proteins) within EVs and their functional impact.
- Examination of EV roles in both physiological and pathological cardiovascular states.
Main Results:
- EVs derived from cardiovascular cells modulate recipient cell functions, impacting gene expression and cellular behavior.
- Under physiological conditions, EVs contribute to maintaining cardiac structure and function.
- Pathological conditions alter EV cargo, promoting the development and progression of CVDs.
Conclusions:
- Extracellular vesicles (EVs) represent a significant mechanism for intercellular communication relevant to cardiovascular health.
- Dysregulated EV function and cargo are implicated in the pathogenesis of various cardiovascular diseases (CVDs).
- EVs hold substantial promise for the development of innovative strategies for CVD prevention, diagnosis, and treatment.
Abstract:
Due to the continued high incidence and mortality rate worldwide, there is still a need to develop new strategies for the prevention, diagnosis and treatment of cardiovascular diseases (CVDs). Proper cardiovascular function depends on the coordinated interplay and communication between cardiomyocytes and noncardiomyocytes. Extracellular vesicles (EVs) are enclosed in a lipid bilayer and represent a significant mechanism for intracellular communication. By containing and transporting various bioactive molecules, such as micro-ribonucleic acids (miRs) and proteins, to target cells, EVs impart favourable, neutral or detrimental effects on recipient cells, such as modulating gene expression, influencing cell phenotype, affecting molecular pathways and mediating biological behaviours. EVs can be released by cardiovascular system-related cells, such as cardiomyocytes, endotheliocytes, fibroblasts, platelets, smooth muscle cells, leucocytes, monocytes and macrophages. EVs containing miRs and proteins regulate a multitude of diverse functions in target cells, maintaining cardiovascular balance and health or inducing pathological changes in CVDs. On the one hand, miRs and proteins transferred by EVs play biological roles in maintaining normal cardiac structure and function under physiological conditions. On the other hand, EVs change the composition of their miR and protein cargoes under pathological conditions, which gives rise to the development of CVDs. Therefore, EVs hold tremendous potential to prevent, diagnose and treat CVDs. The current article reviews the specific functions of EVs in different CVDs.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Coronary Artery Disease II: Pathophysiology
Intralumenal Vesicles and Multivesicular Bodies
Cardiovascular Drugs: Classification based on Therapeutic Indications

